Local delivery of interleukin 7 with an oncolytic adenovirus activates tumor-infiltrating lymphocytes and causes tumor regression-Reference-Cited by-同舟云学术

Local delivery of interleukin 7 with an oncolytic adenovirus activates tumor-infiltrating lymphocytes and causes tumor regression

Published:2022-07-12 Issue:1 Volume:11 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Kudling Tatiana V.¹,Clubb James H.A.¹²,Quixabeira Dafne C.A.¹,Santos Joao M.¹²,Havunen Riikka¹²,Kononov Alexander³,Heiniö Camilla¹,Cervera-Carrascon Victor¹²,Pakola Santeri¹⁴,Basnet Saru¹,Grönberg-Vähä-Koskela Susanna¹⁴,Arias Victor¹,Gladwyn-Ng Ivan⁵,Aro Katri⁴⁶,Bäck Leif⁴⁶,Räsänen Jari⁷,Ilonen Ilkka⁷,Borenius Kristian⁷,Räsänen Mikko⁷,Hemminki Otto⁴⁸,Rannikko Antti⁴⁸,Kanerva Anna¹⁴⁹,Tapper Johanna⁴⁹,Hemminki Akseli¹²⁴^ORCID

Affiliation:

1. Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland

2. TILT Biotherapeutics Ltd, Helsinki, Finland

3. Systems Oncology Group, Cancer research UK, Manchester University, Manchester, UK

4. Comprehensive Cancer Center, Helsinki University Hospital (HUS), Helsinki, Finland

5. Taconic Biosciences GmbH, Leverkusen, Germany

6. Department of Otorhinolaryngology – Head and Neck Surgery, Helsinki Head and Neck Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland

7. Department of Thoracic Surgery, Heart and Lung Center, Helsinki University Hospital and Faculty of Medicine, University of Helsinki, Helsinki, Finland

8. Department of Urology, Helsinki University Hospital, Helsinki, Finland

9. Department of Gynecology and Obstetrics, Helsinki University Hospital, Helsinki, Finland

Funder

Doctoral programme in clinical research

TILT Biotherapeutics Ltd

Suomen Kulttuurirahasto

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2022.2096572